Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Article   |    
TRIDIONE THERAPY Special Aspects of Its Clinical Use
Am J Psychiatry 1947;104:247-253.
View Author and Article Information

The Children's Neurology Clinic of Cook County Hospital, Chicago, and St. John's Home and Hospital for Crippled Children, Springfield, Illinois.

text A A A
PDF of the full text article.

1. A progress report of clinical observations in the therapeutic use of tridione on 136 cases of varied neurological manifestations, over a period of 2 years, is presented.2. As previously reported, most spectacular benefits were obtained in cases of petit mal, where clinical improvement was immediate, associated with improvement in [SEE TABLE2 IN SOURCE PDF] the EEG pattern, and sustained often after cessation of the drug.3. Tridione appears to be useful as an adjuvant drug in the treatment of grand mal seizures, though it does seem to aggravate some cases.4. Both grand and petit mal of the idiopathic type were more responsive than those due to organic lesions.5. Anticonvulsant action is indicated by its beneficial effects in cases of tetanus.6. Tridione is of value in cerebral palsy, especially for reducing tension of the athetoid type.7. Some forms of behavior disturbances are sedated by tridione.8. Site of action for tridione appears to be the midbrain and (with some selectivity) the basal nuclei, an inference drawn from its failure to help patients with pyramidal lesions, while markedly benefiting extra-pyramidal lesions, with the exception of chorea, parkinsonism, and dystonia.9. Toxic side-effects in the use of tridione, in our experience, were rare in children, were generally innocuous, and seemed readily reversible with cessation of the drug. More severe reactions were seen in adults.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Web of Science® Times Cited: 13

Related Content
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 10.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 12.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 10.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 14.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 27.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
[Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry]. Schweiz Arch Neurol Neurochir Psychiatr 1979;125(2):265-9.